- Cambio Climático: El Impacto de la Actividad Humana en el Medio Ambiente y la Necesidad de Acción Colectivaon 19/04/2024
El cambio climático es uno de los desafíos más significativos de nuestro tiempo, influenciado en gran medida por las actividades humanas que han modificado la atmósfera de la Tierra desde la Revolución Industrial. La quema de combustibles fósiles, la defores …
- Mitos y conceptos erróneos sobre los dinosaurioson 19/04/2024
El enigmático mundo de los dinosaurios ha cautivado la imaginación humana durante siglos, pero junto a esta fascinación ha crecido un jardín de mitos y conceptos erróneos. Desde su representación en el cine hasta los malentendidos sobre su propia naturaleza, …
- Cómo se calculan las distancias extragalácticason 19/04/2024
La medición precisa de las distancias entre objetos celestes es fundamental para comprender la estructura y la evolución del universo. Calcular las distancias a las galaxias más allá de la Vía Láctea ha sido un desafío histórico para los astr&o …
- La formación de una estrella enana blancaon 19/04/2024
La formación de estrellas es uno de los fenómenos más impresionantes y misteriosos. Entre las diversas etapas de evolución estelar, la transformación de una estrella enana blanca es un proceso intrigante que desafía nuestra comprensión y nos sumerge e …
- Avances en cables transatlánticos y su instalación en el océano profundoon 19/04/2024
En la era digital, la conectividad global es fundamental para el intercambio de información y el funcionamiento de la economía mundial. Los cables transatlánticos submarinos, junto con los satélites, desempeñan un papel crucial en esta conectividad, permitiendo la …
- Vida y contribuciones de J.J. Thomson al mundo de la cienciaon 19/04/2024
En la historia de la ciencia, pocas figuras brillan con tanto esplendor como J.J. Thomson, cuyas contribuciones revolucionarias allanaron el camino para la comprensión moderna de la estructura del átomo. Desde su descubrimiento del electrón hasta su liderazgo en la investigaci&o …
- El futuro de la energía térmica y las tecnologías de almacenamientoon 19/04/2024
Buscando soluciones sostenibles para satisfacer nuestras crecientes necesidades energéticas, la innovación en el campo de la energía térmica y el almacenamiento está adoptando un papel protagonista. En este emocionante período de avances tecnológicos, …
- Explorando el cosmos desde la Lunaon 19/04/2024
La exploración del espacio exterior ha sido una búsqueda constante de la humanidad, y la Luna ha emergido como un punto de partida estratégico para nuestra exploración cósmica. En esta era de descubrimiento, la idea de establecer telescopios en la Luna ha capturado …
- Las principales causas de infertilidad femeninaon 19/04/2024
La infertilidad femenina es un desafío que afecta a millones de mujeres en todo el mundo, y comprender sus causas es fundamental para abordar este problema de manera efectiva. Desde trastornos hormonales hasta factores ambientales, diversas variables pueden influir en la capacidad de una muje …
- Prescient Healthcare Group Appoints Two New Members to its Board of Directorson 19/04/2024
Prescient Healthcare Group , a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient’s global mission.
- Concord Medical Files 2023 Annual Report on Form 20-Fon 19/04/2024
Concord Medical Services Holdings Limited today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the “Annual Report”) with the U.S. Securities and Exchange Commission.
- Stemtech Corporation on Track for CEO and Chairman’s Goal for Growth and Global Expansionon 19/04/2024
Stemtech Corporation is proud to announce that it is on track to achieve the CEO and Chairman’s goal of becoming cash flow positive.
- YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024on 19/04/2024
YS Biopharma Co., Ltd. today announced its unaudited consolidated financial results for the first nine months of the fiscal year ended March 31, 2024.
- ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES) Conference 2024on 19/04/2024
ARTHEx Biotech S.L. announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics Conference 2024, being held in a hybrid format May 14-17, 2024 in Boston and online.
- Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinomaon 19/04/2024
Merck announced that Health Canada has granted approval of KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the first-line treatment of adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma.
- GenFleet Therapeutics Announces FDA’s Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Canceron 19/04/2024
GenFleet Therapeutics announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a multi-center, open-label, randomized and controlled phase III study treating refractory metastatic colorectal cancer (CRC) patients.
- Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)on 19/04/2024
Alvotech announced a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the U.S. market, the newly U.S. Food and Drug Administration approved high-concentration interchangeable biosimilar to Humira.
- Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Awardon 19/04/2024
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in the National Academy of Sciences building in Washington D.C.
- Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuringon 19/04/2024
French healthcare and pharma company Sanofi will terminate an undisclosed number of positions in its U.S. vaccines commercial unit in an effort to streamline the strategic sales structure.
- Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®on 19/04/2024
Tiziana Life Sciences, Ltd. today announced that a study related to its lead candidate, foralumab, was highlighted in Neurology Today®, the official news source of the American Academy of Neurology (AAN), in an article titled, “Anti-CD3 Antibody Foralumab Shows Promise in PIRA, Measured by Novel PET Ligand.”
- Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officeron 19/04/2024
Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Type 1 Diabetes Mellitus, announces the appointment of Aurelia Caparrós as the Company’s new Chief Business Officer, effective 1st of April 2024.
- PharmAla Closes Private Placement and Concurrent Debt Settlementon 19/04/2024
PharmAla Biotech Holdings Inc. is pleased to announce that, further to its press release dated April 10, 2024 (the “ April 10 Release ”), the Company has closed its previously announced non-brokered private placement offering.
- CorMedix Inc. Announces CMS Grants TDAPA to DefenCathon 19/04/2024
CorMedix Inc. today announced that the Center for Medicare & Medicaid Services (CMS) has determined that DefenCath ® meets the criteria for a Transitional Drug Add-On Payment (TDAPA) in the anti-infective functional category, beginning on July 1, 2024.
- Lifeward Announces the Appointment of Mike Swinford to its Board of Directorson 19/04/2024
ReWalk Robotics Ltd. announced that the Board has approved the appointment of Mike Swinford to the Board of Directors, effective April 18, 2024.